• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柳氮磺胺吡啶对IgE介导的肥大细胞脱颗粒的抑制作用。

Inhibition of IgE-mediated mast cell degranulation by sulphasalazine.

作者信息

Barrett K E, Tashof T L, Metcalfe D D

出版信息

Eur J Pharmacol. 1985 Jan 2;107(2):279-81. doi: 10.1016/0014-2999(85)90071-8.

DOI:10.1016/0014-2999(85)90071-8
PMID:2579829
Abstract

The effect of sulphasalazine on two mast cell populations and human peripheral leukocytes is reported. Sulphasalazine inhibited histamine release from mouse and rat mast cells, but it caused a potentiation of secretion in human peripheral leukocytes. The drug alone did not induce histamine release when administered without an anaphylactic stimulus. The results are discussed in terms of a possible mode of action of sulphasalazine in the treatment of inflammatory bowel disease.

摘要

报告了柳氮磺胺吡啶对两种肥大细胞群体和人外周血白细胞的作用。柳氮磺胺吡啶抑制小鼠和大鼠肥大细胞释放组胺,但它会增强人外周血白细胞的分泌。在没有过敏刺激的情况下给药时,该药物单独不会诱导组胺释放。根据柳氮磺胺吡啶在治疗炎症性肠病中的可能作用方式对结果进行了讨论。

相似文献

1
Inhibition of IgE-mediated mast cell degranulation by sulphasalazine.柳氮磺胺吡啶对IgE介导的肥大细胞脱颗粒的抑制作用。
Eur J Pharmacol. 1985 Jan 2;107(2):279-81. doi: 10.1016/0014-2999(85)90071-8.
2
Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid.
Dig Dis Sci. 1991 Feb;36(2):179-84. doi: 10.1007/BF01300753.
3
Effect of sulphasalazine and balsalazide on histamine release from mast cells.柳氮磺吡啶和巴柳氮对肥大细胞组胺释放的影响。
Inflamm Res. 2007 Apr;56 Suppl 1:S9-10. doi: 10.1007/s00011-006-0504-z.
4
Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells.糖皮质激素诱导抑制小鼠肥大细胞中IgE介导的组胺释放的生化分析。
J Immunol. 1982 Sep;129(3):1212-8.
5
The effect of rat mast cell sensitization with mouse IgE antibody on anaphylactic histamine release by anti-mouse IgE and Con A.用小鼠IgE抗体致敏大鼠肥大细胞对抗小鼠IgE和刀豆蛋白A诱导的过敏组胺释放的影响。
Arch Immunol Ther Exp (Warsz). 1985;33(4):531-8.
6
Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism.腺苷通过A2嘌呤受体介导的机制抑制并增强人肺肥大细胞中IgE依赖的组胺释放。
Biochem Pharmacol. 1984 Dec 1;33(23):3847-52. doi: 10.1016/0006-2952(84)90050-9.
7
Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.灵长类支气管肺泡肥大细胞的特性。II. 对灵长类支气管肺泡肥大细胞组胺、白三烯C4和前列腺素D2释放的抑制作用以及与大鼠腹腔肥大细胞的比较。
J Immunol. 1986 Dec 15;137(12):3941-5.
8
Aspergillus oryzae lectin induces anaphylactoid oedema and mast cell activation through its interaction with fucose of mast cell-bound non-specific IgE.米曲霉凝集素通过与结合在肥大细胞上的非特异性 IgE 中的岩藻糖相互作用,诱导过敏样水肿和肥大细胞活化。
Scand J Immunol. 2011 Nov;74(5):445-53. doi: 10.1111/j.1365-3083.2011.02598.x.
9
The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.人重组c-kit受体配体rhSCF可诱导人皮肤肥大细胞释放介质,并增强皮肤肥大细胞和外周血嗜碱性粒细胞依赖IgE的介质释放。
J Immunol. 1992 Jul 15;149(2):599-608.
10
High rate of IgE-mediated histamine release from rat mesenteric mast cells.大鼠肠系膜肥大细胞中IgE介导的组胺释放率高。
Exp Anim. 2001 Apr;50(2):187-90. doi: 10.1538/expanim.50.187.

引用本文的文献

1
A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis.一项关于酪氨酸激酶抑制剂尼洛替尼治疗脊柱关节炎的概念验证研究。
J Transl Med. 2016 Oct 27;14(1):308. doi: 10.1186/s12967-016-1050-2.
2
Mechanism of action of 5-arninosalicylic acid.5-氨基水杨酸的作用机制。
Mediators Inflamm. 1992;1(3):151-65. doi: 10.1155/S0962935192000243.
3
Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.强直性脊柱炎和类风湿关节炎患者体内循环抑制物结合弹性蛋白酶及柳氮磺胺吡啶治疗的影响
Ann Rheum Dis. 1988 Jan;47(1):10-4. doi: 10.1136/ard.47.1.10.
4
The protective effects of sulphasalazine against ethanol-induced gastric damage in rats.柳氮磺胺吡啶对大鼠乙醇诱导的胃损伤的保护作用。
Br J Pharmacol. 1987 Sep;92(1):31-7. doi: 10.1111/j.1476-5381.1987.tb11292.x.
5
Sulphasalazine and regression of rheumatoid nodules.柳氮磺胺吡啶与类风湿结节的消退
Ann Rheum Dis. 1987 Mar;46(3):244-5. doi: 10.1136/ard.46.3.244.
6
Sulphasalazine and experimental stress ulcers.柳氮磺胺吡啶与实验性应激性溃疡
Agents Actions. 1985 Dec;17(2):153-7. doi: 10.1007/BF01966585.
7
Inflammatory bowel disease.炎症性肠病
CMAJ. 1989 Jul 15;141(2):113-23; discussion 123-4.
8
Mast cell polymorphisms. Present concepts, future directions.肥大细胞多态性。当前概念与未来方向。
Dig Dis Sci. 1988 Mar;33(3 Suppl):16S-24S. doi: 10.1007/BF01538127.
9
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.用于炎症性肠病的水杨酸盐和秋水仙碱会损害干扰素-γ诱导的HLA-DR表达。
Gut. 1992 Jan;33(1):59-64. doi: 10.1136/gut.33.1.59.
10
Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid.
Dig Dis Sci. 1991 Feb;36(2):179-84. doi: 10.1007/BF01300753.